The Leaf THE LEAF March-April 2019 | Page 7

For the Past 17 Years, Montel Williams Did What the FDA Won't: He Made Weed A Medicine By Janet Burns ‘Forbes Magazine’ 20 th April 2017 After being diagnosed with multiple sclerosis (MS) in 2000, Montel Williams set out to find the safest, most effective form of medicinal cannabis for treating his disease and others, and to bring that product to the masses. He explained by phone that the medicinal and recreational booms have also brought a huge rise in the number of different cannabis producers, all operating under fluctuating, often ill-defined regulatory standards. "We've got a lot of 'garage scientists' in the industry, who are well-meaning people— I don't think anyone gets up in the morning, goes to the garage, and thinks they’ll make something poisonous that could hurt people," he said. "But some are misled, some don't do the research, and some don’t understand how long it’s taken to get here, and just work from bits and pieces of the extant literature," he continued. "If you looked at how some of these products are processed, you would not give it to your mother or your child. So why do we call it medicine?" After 17 years of nonstop research and advocacy, those goals are finally in hand with the launch of his new, medical-grade line of cannabis oils and products--but don't expect him to slow down anytime soon. Now serving medicinal cannabis patients in California (and other states soon), Lenitiv Labs is the product of nearly two decades of research spanning multiple continents and continuous, very personal investment by Williams. As founder, the retired naval officer, former TV host, and ongoing entrepreneur has guaranteed to personally try every batch of cannabis concentrate he sells, having spent years learning how other companies process the plant for use in 'medical' products. Williams, whose company recovers active and medicinal chemicals like THC and CBD from cannabis plants using the 'green method' of supercritical fluid extraction (SFE) with C02, noted that the butane, hexane and flavouring used to process much consumer- grade cannabis can leave unwanted traces behind. "With specialty beers, sure, include all the novelty junk you want. But if you call it medicine, and give it to anyone with a serious disease such as MS, epilepsy, fibromyalgia, and on and on, you must believe that they're walking in that door trusting that it will work, and not do them harm."